The impaired IL-10 response in presence of high glucose can justify the increased frequency of mortality and severe complication in COVID-19 patients with diabetes or hyperglycemia and the better outcomes associated with improved glycemic control (236, 240). This evidence concerns the gene IL10 and COVID-19.